Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 4,738

Document Document Title
WO/2008/034316
The present invention discloses a compound preparation for reducing oxidative stress rapidly, which comprises micromolecule compounds capable of eliminating free radical and regulating endocrine system and digestive system, mineral micro...  
WO/2008/035583
Disclosed are a moisturizing agent, a cell-activating agent, an antioxidant agent, a protease activity-enhancing agent, an anti-aging agent, a skin-whitening agent, an anti-inflammatory agent, and a neutral fat accumulation-inhibiting ag...  
WO/2008/036056
The inventive method for producing a sorbent consists in adding a strong acid solution to a methylsiliconate sodium (or potassium) solution for obtaining a product, which after being stabilised, is ground and activated by adding a strong...  
WO/2008/036056
The inventive method for producing a sorbent consists in adding a strong acid solution to a methylsiliconate sodium (or potassium) solution for obtaining a product, which after being stabilised, is ground and activated by adding a strong...  
WO/2008/035566
A cell activator, a collagen production promoter, a collagenase activity inhibitor, a melanin formation inhibitor, an antioxidant agent, an antiinflammatory agent, a fat accumulation inhibitor, a protease activity promoter, an external p...  
WO/2008/033545
The present invention is directed to the use of a compound having the formula (I), wherein R1, R2, R3, m, n and p are defined herein. The compounds of the present invention are useful as inhibitors of certain taste perceptions and functi...  
WO/2008/029877
Disclosed are an anti-aging agent, a skin-whitening agent, an anti-oxidative agent and an anti-inflammatory agent, each comprising a plant Glias nueberthii or an extract thereof as an active ingredient. Further disclosed are various comp...  
WO/2008/029879
A moisturizing agent, a cell-activating agent and an antioxidant containing as an active ingredient one or more types of plants selected from the plants of the Molluginaceae genus or an extract thereof are disclosed. Further, various com...  
WO/2008/026904
The invention relates to an antidote composition which is used to treat a patient suffering from poisoning resulting from the inoculation of venomous substances following a sting or a bite from a poisonous animal. According to the invent...  
WO/2008/025163
The present invention provides AMPAR excitotoxicity mediating polypeptides comprising the GluR2 NT1 -3-2 (Y142-K172) amino acid sequence (SEQ ID NO:1) or the GAPDH(2-2-1-1) (I221-E250)amino acid sequence (SEQ ID NO:2). Also disclosed are...  
WO/2008/022365
The use of galanthamine of the formula (I) and derivatives or analogues of galanthamine for controlling the effect of toxic organic phosphorus compounds such as parathion, paraxon, sarin, soman or tabun is described, wherein a compositio...  
WO/2008/024021
The invention relates to the pharmaceutical industry and to medicine, in particular to a novel highly active antioxidant which is used for preventing and treating diseases caused by oxidative stress and scarcity of oxygen in an organism ...  
WO/2008/022365
The use of galanthamine of the formula (I) and derivatives or analogues of galanthamine for controlling the effect of toxic organic phosphorus compounds such as parathion, paraxon, sarin, soman or tabun is described, wherein a compositio...  
WO/2008/018133
The invention relates to a moisturizing agent, a cell-activating agent, a skin-whitening agent, an agent for suppressing triglyceride accumulation and an antioxidant containing as an active ingredient, one or more plants selected from pl...  
WO/2008/018142
It is intended to provide a composition which exerts an excellent antioxidant effect in vivo. Namely, an antioxidant composition characterized by containing a component originating in the bark of a tree belonging to the genus Acacia.  
WO/2008/015867
Disclosed is a method for activating dissolved hydrogen molecules in water and stabilizing the hydrogen molecule concentration. Specifically disclosed is a method for activating and stabilizing dissolved hydrogen molecules in water, whic...  
WO/2008/016378
The present invention relates to methods useful for treating and/ or preventing radiation- and/ or chemical-induced toxicity in non-malignant tissue using a protease activated receptor- 1 (PAR-I) inhibitor. In particular, use of a protea...  
WO/2008/016378
The present invention relates to methods useful for treating and/ or preventing radiation- and/ or chemical-induced toxicity in non-malignant tissue using a protease activated receptor- 1 (PAR-I) inhibitor. In particular, use of a protea...  
WO/2008/016123
Disclosed is a GSK-3β inhibitor comprising an oxadiazole compound or a salt or prodrug thereof which is useful as a prophylactic/therapeutic agent for a GSK-3β-related condition or disease. The GSK-3β inhibitor comprises a compound re...  
WO/2008/013219
Disclosed is a composition which enables the increased in-vivo absorption of cryptoxanthin derived from a natural product, particularly cryptoxanthin derived from Unshu-orange which is known to contain cryptoxanthin in a large quantity. ...  
WO/2008/010403
The invention is directed to a method for preventing coloration of catechins by adding to catechins, a water-soluble polymer capable of forming a water-insoluble complex with catechins; and hydrogel particles containing a water-insoluble...  
WO/2007/147590
The present invention concerns a solution and methods to reduce, treat and/or prevent oxidative stress and cell activation. According to the invention the solution gives rise to the following concentrations of constituents within a blood...  
WO/2007/147590
The present invention concerns a solution and methods to reduce, treat and/or prevent oxidative stress and cell activation. According to the invention the solution gives rise to the following concentrations of constituents within a blood...  
WO/2007/145682
A composition for oral radionuclide chelation therapy comprises a DTPA chelate selected from Zn-DTPA and Ca-DTPA and a permeation enhancer that preferentially increases jejunal uptake of the DTPA chelate. The composition has a DTPA chela...  
WO/2007/143858
Diphtheria and Pseudomonas infections are very common worldwide. The toxins involved in the pathogenesis of those diseases act by inactivating the elongation factor-2 (EF-2), therefore blocking protein synthesis and leading to cell death...  
WO/2007/143851
The present application concerns plant extracts which have been fermented with kephir grains, methods of production of these extracts, a powder comprising these extracts and compositions comprising these extracts. Since these extracts ha...  
WO/2007/140551
The present invention relates to the use of vanilloid receptor (VR) antagonists, and more particularly vanilloid receptor 1 (VR1) antagonist, as analgesics in the treatment and/or prohylaxis of cnidaria envenomations.  
WO/2007/143066
Provided is a method for determining whether an individual is likely to be susceptible to radiation pneumonitis from radiation therapy and for developing a treatment based on the determination of susceptibility. The method involves measu...  
WO/2007/140551
The present invention relates to the use of vanilloid receptor (VR) antagonists, and more particularly vanilloid receptor 1 (VR1) antagonist, as analgesics in the treatment and/or prohylaxis of cnidaria envenomations.  
WO/2007/139153
It is intended to provide a function-improving agent for cerebral dysfunction caused by an environmental chemical. According to the invention, the function-improving agent for cerebral dysfunction caused by an environmental chemical cont...  
WO/2007/135241
This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/...  
WO/2007/135241
This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/...  
WO/2007/135242
This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/...  
WO/2007/133076
The current invention provides new methods and means for the prevention and treatment of ageing-related symptoms and diseases. The invention discloses mannitol and/or proline containing compositions that are particularly useful for the t...  
WO/2007/133076
The current invention provides new methods and means for the prevention and treatment of ageing-related symptoms and diseases. The invention discloses mannitol and/or proline containing compositions that are particularly useful for the t...  
WO/2007/132418
The present invention concerns to the use of salicylate in the treatment of mammal intoxications caused by the herbicide paraquat (PQ). It was achieved, for the first time, 100% of survival 30 days after the administration to Wistar rats...  
WO/2007/125946
Disclosed are: an antioxidant agent which comprises, as an active ingredient, a peptide having an antioxidative effect and an adiponectin production-promoting effect and comprising the amino acid sequence represented by the formula: His-...  
WO/2007/124610
The present invention concerns an antibody specific for human ALK (Anaplastic Lymphoma Kinase), in particular a scFv, a nucleic acid sequence encoding it, its production and its use as a pharmaceutical or for diagnostic purposes. Said an...  
WO/2007/125832
A new action of Helipyrone A is now found. As a useful application of Helipyrone A, the following agent is disclosed: a singlet oxygen scavenger, an anti-skin-aging agent, an anti-wrinkle agent, an anti-sagging agent, an agent for improv...  
WO/2007/124734
A compound of the formula A-R-X or pharmaceutically acceptable salts thereof can be used to manufacture a pharmaceutical preparation which serves to prevent or treat cancers, pathological sequelae of alcohol abuse, viral hepatitis, steat...  
WO/2007/124734
A compound of the formula A-R-X or pharmaceutically acceptable salts thereof can be used to manufacture a pharmaceutical preparation which serves to prevent or treat cancers, pathological sequelae of alcohol abuse, viral hepatitis, steat...  
WO/2007/123284
The present invention relates to an alpha lipoic acid capsule composition stabilized in aqueous phase, which can effectively prevent alpha lipoic acid from decomposing due to external environmental conditions, such as water, temperature,...  
WO/2007/119367
Tetrahydrobiopterin (BH4) to be used as a pharmaceutical has an excellent efficacy, therefore, expansion of use or application thereof is considered. However, because BH4 is expensive and unstable to oxidation, its application to other t...  
WO/2007/118276
The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or ot...  
WO/2007/118967
This invention relates to the use of cholest-4-in-3-one derivatives to obtain a cytoprotective medicine, excluding a neuroprotective medicine.  
WO/2007/116916
[PROBLEMS] To provide a liquid drug preparation for oral preparation by which the labor at drug-taking can be saved to thereby reduce patient burden and which enables safe drug-taking. [MEANS FOR SOLVING PROBLEMS] A liquid drug preparati...  
WO/2007/114791
The invention relates to a pharmaceutical composition containing 250 to 5000 millimoles per liter of lactate or lactic acid, 0.5 to 1.99 millimoles per liter of calcium and optionally 2 to 10 millimoles per liter of potassium. The invent...  
WO/2007/114461
Disclosed is a process for production of a composition having a carotenoid content of 80% or more, which comprises: extracting a culture of a microorganism, a condensation product of the culture or a dried product of the culture or the c...  
WO/2007/109893
The present invention relates to compositions and methods for reducing the cellular toxicity of a fume, particularly in relation to pulmonary inflammation, cytokine imbalance and lung disease. Plant extracts to be used with the compositi...  
WO/2007/109892
The present invention relates to compositions and methods for reducing the concentration of noxious substances in gases and smoke. Filters comprising plant extracts, such as parenchyma tissue extract and mesophyll cell extract, are also ...  

Matches 551 - 600 out of 4,738